CorMedix Inc. (NASDAQ:CRMD) will release its fourth-quarter financial results, before the opening bell, on Tuesday, March 25.
Analysts expect the Berkeley Heights, New Jersey-based company to report quarterly earnings at 14 cents per share, versus a year-ago loss of 26 cents per share in the year-ago period. CorMedix projects quarterly revenue of $28.34 million, according to data from Benzinga Pro.
On Jan. 21, CorMedix disclosed that it has engaged with WSI PBG to promote DefenCath® to …
Full story available on Benzinga.com
CorMedix Inc. (NASDAQ:CRMD) will release its fourth-quarter financial results, before the opening bell, on Tuesday, March 25.
Analysts expect the Berkeley Heights, New Jersey-based company to report quarterly earnings at 14 cents per share, versus a year-ago loss of 26 cents per share in the year-ago period. CorMedix projects quarterly revenue of $28.34 million, according to data from Benzinga Pro.
On Jan. 21, CorMedix disclosed that it has engaged with WSI PBG to promote DefenCath® to …
Full story available on Benzinga.com
CorMedix Inc. (NASDAQ:CRMD) will release its fourth-quarter financial results, before the opening bell, on Tuesday, March 25.
Analysts expect the Berkeley Heights, New Jersey-based company to report quarterly earnings at 14 cents per share, versus a year-ago loss of 26 cents per share in the year-ago period. CorMedix projects quarterly revenue of $28.34 million, according to data from Benzinga Pro.
On Jan. 21, CorMedix disclosed that it has engaged with WSI PBG to promote DefenCath® to …Full story available on Benzinga.com Read MoreCRMD, Earnings, Expert Ideas, Most Accurate Analysts, News, Price Target, Markets, Trading Ideas, CRMD, News, Earnings, Price Target, Markets, Trading Ideas, Benzinga Markets
